Finch Therapeutics Group (FNCH) Competitors

Finch Therapeutics Group (NASDAQ:FNCH) and 22nd Century Group (NASDAQ:XXII) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Is FNCH or XXII more profitable?

Finch Therapeutics Group has a net margin of 0.00% compared to 22nd Century Group's net margin of -233.06%. Finch Therapeutics Group's return on equity of -68.11% beat 22nd Century Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Finch Therapeutics Group	N/A	-68.11%	-28.10%
22nd Century Group	-233.06%	-380.39%	-104.60%

Do analysts rate FNCH or XXII?

22nd Century Group has a consensus price target of $100.00, suggesting a potential upside of 12,720.51%. Given 22nd Century Group's higher possible upside, analysts clearly believe 22nd Century Group is more favorable than Finch Therapeutics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Finch Therapeutics Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
22nd Century Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has better earnings and valuation, FNCH or XXII?

Finch Therapeutics Group has higher earnings, but lower revenue than 22nd Century Group. Finch Therapeutics Group is trading at a lower price-to-earnings ratio than 22nd Century Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Finch Therapeutics Group	$110K	27.22	-$74.75M	-$10.14	-0.18
22nd Century Group	$32.20M	0.20	-$140.77M	-$102.62	-0.01

Does the MarketBeat Community prefer FNCH or XXII?

22nd Century Group received 345 more outperform votes than Finch Therapeutics Group when rated by MarketBeat users. Likewise, 68.93% of users gave 22nd Century Group an outperform vote while only 52.63% of users gave Finch Therapeutics Group an outperform vote.

Company	Underperform	Outperform
Finch Therapeutics Group	Outperform Votes 10 52.63%	Underperform Votes 9 47.37%
22nd Century Group	Outperform Votes 355 68.93%	Underperform Votes 160 31.07%

Do insiders and institutionals hold more shares of FNCH or XXII?

21.8% of Finch Therapeutics Group shares are owned by institutional investors. Comparatively, 18.1% of 22nd Century Group shares are owned by institutional investors. 44.9% of Finch Therapeutics Group shares are owned by company insiders. Comparatively, 0.4% of 22nd Century Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more volatility and risk, FNCH or XXII?

Finch Therapeutics Group has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. Comparatively, 22nd Century Group has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500.

Does the media refer more to FNCH or XXII?

In the previous week, 22nd Century Group had 2 more articles in the media than Finch Therapeutics Group. MarketBeat recorded 2 mentions for 22nd Century Group and 0 mentions for Finch Therapeutics Group. 22nd Century Group's average media sentiment score of 1.44 beat Finch Therapeutics Group's score of 0.00 indicating that 22nd Century Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Finch Therapeutics Group	Neutral
22nd Century Group	Positive

Summary

22nd Century Group beats Finch Therapeutics Group on 9 of the 17 factors compared between the two stocks.